compound semaglutide hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over Novo Nordisk Abruptly Ends Partnership

The tirzepatide enforcement shift The FDA determined that the tirzepatide shortage was resolved, and Eli Lilly demonstrated adequate supply

In a pre-specified blinded extension for those with a BMI 35, participants who continued on retatrutide 12 mg to 104 weeks lost an average of 85.0 lbs (30.3%)

Liraglutide, or Victoza, has come off patent in June of 2024 but requires a daily injection instead of weekly

A vial stored at room temperature for three weeks can look identical to one kept properly in the refrigerator, yet contain only 60 percent of the original active compound

Muscle-Related Symptoms in GLP-1 Clinical Trials: What the Evidence Shows Clinical trials of semaglutide and other GLP-1 agonists track adverse events systematically